跳至主要内容
临床试验/CTRI/2024/06/068980
CTRI/2024/06/068980尚未招募3 期

A Double-Blind, Randomized, Placebo-Controlled Trial of Individualized Homoeopathy for the treatment of Early Haemorrhoidal Disease - NI

Central Council for Research in Homoeopathy, Ministry of AYUSH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from idiopathic/ primary grade I and grade II hemorrhoids presenting with any of the symptoms namely bleeding, pain (tenesmus), heaviness, pruritis, and mucus discharge with or without anitis.
  • 2. Patients with known but controlled diabetes (glycated hemoglobin less than 8 %) and controlled hypertension and thyroid disorders will also be eligible for the study.
  • 3. Patients using topical agents for hemorrhoids will be included after a washout period of one week, subject to persistence of symptoms and signs of hemorrhoids.

排除标准

  • 1. Grade III and IV piles, anal fissure and fistula.
  • 2. Patients with uncontrolled diabetes, hypertension and thyroid disorders.
  • 3. Known case of hereditary piles, inflammatory bowel disease, enlarged prostate, chronic alcoholism, cirrhotic liver disease, recreational drug abuse, coagulation disorders, external hemorrhoids, previous history of surgery for hemorrhoids, hypertrophic anal papillae, rectal malignancies, history of leukemic disorders, patients with obstruction of portal circulation, pregnancy leading to obstruction of the portal circulation, lactating mothers, patients with psychiatric diseases.
  • 4. Patients of Hemorrhoids with symptomatology of other than predefined drugs.

研究者

发起方
Central Council for Research in Homoeopathy, Ministry of AYUSH

相似试验